Group B strep (GBS) is a bacterial infection caused by Streptococcus agalactiae, which can spread through sexual contact but is not classified as a traditional sexually transmitted infection (STI). The bacteria typically live harmlessly in the intestines, urinary tract, or genital tract.
GBS can be transmitted through vaginal fluids during sexual activity, though it is not as contagious as other STIs. The bacteria can also spread during childbirth, leading to serious infections in newborns. Unlike common STIs like chlamydia or gonorrhea, GBS does not always cause noticeable symptoms.
Many people with GBS show no symptoms. When symptoms appear, they may include fever, burning during urination, or vaginal discharge. In severe cases, GBS can lead to life-threatening infections such as sepsis, pneumonia, or meningitis, particularly in newborns and immunocompromised individuals.
Pregnant women colonized with GBS can pass the bacteria to their babies during childbirth, potentially causing serious complications like neonatal sepsis or meningitis. This risk is why prenatal screening and treatment are important.
Antibiotics are the primary treatment for GBS infections. Pregnant women who test positive for GBS receive intravenous antibiotics during labor to prevent transmission to the baby. While antibiotics can cure active infections, they do not eliminate the bacteria from the body permanently, meaning reinfection is possible.
To reduce the risk of GBS transmission, practice safe sex, maintain good hygiene, and seek medical attention if symptoms develop. Regular prenatal care and screening are essential for pregnant women to manage GBS effectively.
If you suspect a GBS infection, consult a healthcare provider for proper diagnosis and treatment. Early intervention can prevent severe complications and protect both adults and newborns from harm.